Replies to post #227539 on Biotech Values

[randychub]

Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA) today announced that it is commencing an underwritten registered public offering of $200,000,000 of shares of its common stock. Momenta also expects to grant the underwriters of the offering an option to purchase up to an additional $30,000,000 of shares of its common stock

[mouton29]

RVNC public offering -- I took a shot and e-mailed the company and asked if, consistent with past practice, they would announce the closing of the offering and they replied with a statement that, at this point, they have only issued the supplement and pricing release.